Evolution of Biologics Screening Technologies

Author： Cariuk Peter   Gardener Matthew J.   Vaughan Tristan J.  

Publisher： MDPI

E-ISSN： 1424-8247|6|5|681-688

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.6, Iss.5, 2013-05, pp. : 681-688

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biologics in Dermatology

By Chandler David   Bewley Anthony  

Pharmaceuticals, Vol. 6, Iss. 4, 2013-04 ,pp. : 557-578

MDPI

Access to resources Recommend Favorite

Biosimilars: Company Strategies to Capture Value from the Biologics Market

By Calo-Fernández Bruno   Martínez-Hurtado Juan Leonardo  

Pharmaceuticals, Vol. 5, Iss. 12, 2012-12 ,pp. : 1393-1408

MDPI

Access to resources Recommend Favorite

Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications

By Fiandaca Massimo S.   Bankiewicz Krystof S.   Federoff Howard J.  

Pharmaceuticals, Vol. 5, Iss. 6, 2012-06 ,pp. : 553-590

MDPI

Access to resources Recommend Favorite

Technologies for Single-Cell Isolation

By Gross Andre   Schoendube Jonas   Zimmermann Stefan   Steeb Maximilian   Zengerle Roland   Koltay Peter  

International Journal of Molecular Sciences, Vol. 16, Iss. 8, 2015-07 ,pp. : 16897-16919

MDPI

Access to resources Recommend Favorite

Microfluidic Technologies for Synthetic Biology

By Vinuselvi Parisutham   Park Seongyong   Kim Minseok   Park Jung Min   Kim Taesung   Lee Sung Kuk  

International Journal of Molecular Sciences, Vol. 12, Iss. 6, 2011-06 ,pp. : 3576-3593

MDPI

Access to resources Recommend Favorite